Have you read these stories?

Johnson & Johnson starts phase 3 vaccine trial

US drugmaker Johnson & Johnson says the vaccine could be available for use by early 2021 if proven safe, effective. In the next phase ...
The Economic Times
English EditionEnglish Editionहिन्दीગુજરાતી
| 24 September, 2020, 04:27 AM IST | E-Paper
Search
+

    SEARCHED FOR:EXTERNAL BENCHMARKING LOAN

    Saying goodbye to Libor, the world’s most valuable benchmark

    Transition to alternative reference rates will involve considerable efforts for Libor users.

    IBA asks banks for Libor alternative

    MIFOR is priced after adding a mark-up over Libor, which will cease to exist globally after 2021.

    Loans: Festive season offers and should you take them

    During festival season, banks come out with various special loan offers. These loan off...

    Load More...
    x
    The Economic Times